by jrondon | Apr 9, 2021 |
FEATURED NEWS Projects > Featured News Nammi Therapeutics Unveils Two Novel Immunotherapies at AACR Conference This article was originally published in PR Newswire Nammi Therapeutics, Inc. (Nammi), an LA-based immunotherapy company, announces its first two cancer...
by mroseboro | Jan 2, 2017 |
Partillion Bioscience aims to broaden access to the advanced single-cell tools needed for biomedical innovation with its award-winning nanovial platform. Market: Emerging technologies for treatment and diagnosis rely on the use of cells to produce antibodies and other...
Recent Comments